Chemical modification of alpha(1-3) fucosyltransferase defines residues of catalytic importance.
Britten
C
C
Glycobiology Research Group, Glaxo R & D Ltd., Greenford, Middlesex.
Hood
C
C
Bird
M
M
D000818:Animals; D001120:Arginine; D001665:Binding Sites; D002240:Carbohydrate Sequence; D002460:Cell Line; D003001:Cloning, Molecular; D003545:Cysteine; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005647:Fucosyltransferases / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism*; D006639:Histidine; D006801:Humans; D007700:Kinetics; D008239:Lysine; D008969:Molecular Sequence Data; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D018411:Spodoptera; D014162:Transfection; D014364:Tryptophan
D004791:Enzyme Inhibitors; D011994:Recombinant Proteins; D006639:Histidine; D014364:Tryptophan; D001120:Arginine; D005647:Fucosyltransferases; C031692:galactoside 3-fucosyltransferase; D008239:Lysine; D003545:Cysteine; D005033:Ethylmaleimide